TP Receptor as a Therapeutic Target in Atherosclerosis and Related Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|1|3|241-247

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.1, Iss.3, 2006-11, pp. : 241-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 249-263

Bentham Science Publishers

Access to resources Recommend Favorite

The P2Y12 receptor as a therapeutic target in cardiovascular disease

By Storey R. F.  

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease

By  

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-02 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease

By  

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-01 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

Visfatin/PBEF and Atherosclerosis-Related Diseases

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 12-28

Bentham Science Publishers

Access to resources Recommend Favorite